Nuveen Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-222,679
| Closed | -$23.9M | – | 3341 |
|
|
2023
Q1 | $23.9M | Sell |
222,679
-45,940
| -17% | -$4.93M | 0.01% | 920 |
|
|
2022
Q4 | $29.5M | Sell |
268,619
-66,061
| -20% | -$7.27M | 0.01% | 806 |
|
|
2022
Q3 | $19.7M | Buy |
334,680
+233,507
| +231% | +$13.8M | 0.01% | 1018 |
|
|
2022
Q2 | $2.86M | Sell |
101,173
-19,662
| -16% | -$555K | ﹤0.01% | 2249 |
|
|
2022
Q1 | $5.14M | Sell |
120,835
-7,069
| -6% | -$301K | ﹤0.01% | 2044 |
|
|
2021
Q4 | $4M | Buy |
127,904
+87,973
| +220% | +$2.75M | ﹤0.01% | 2245 |
|
|
2021
Q3 | $1.04M | Buy |
39,931
+7,558
| +23% | +$198K | ﹤0.01% | 2974 |
|
|
2021
Q2 | $795K | Buy |
+32,373
| New | +$795K | ﹤0.01% | 3086 |
|